Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 4 studies | 22% ± 4% | |
glutamatergic neuron | 3 studies | 19% ± 1% |
Insufficient scRNA-seq data for expression of SCML2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 660.94 | 258 / 258 | 93% | 4.16 | 215 / 230 |
ovary | 100% | 712.09 | 180 / 180 | 92% | 3.65 | 395 / 430 |
brain | 97% | 125.43 | 2571 / 2642 | 92% | 3.47 | 650 / 705 |
prostate | 100% | 207.93 | 245 / 245 | 79% | 1.53 | 399 / 502 |
uterus | 100% | 412.55 | 170 / 170 | 78% | 4.92 | 356 / 459 |
breast | 100% | 184.87 | 458 / 459 | 77% | 3.38 | 862 / 1118 |
intestine | 100% | 258.30 | 964 / 966 | 69% | 2.56 | 361 / 527 |
liver | 98% | 116.85 | 222 / 226 | 67% | 2.17 | 273 / 406 |
thymus | 100% | 366.30 | 652 / 653 | 64% | 1.68 | 386 / 605 |
esophagus | 100% | 186.40 | 1445 / 1445 | 62% | 3.21 | 114 / 183 |
skin | 100% | 197.86 | 1806 / 1809 | 59% | 2.56 | 278 / 472 |
lung | 96% | 98.12 | 554 / 578 | 57% | 2.47 | 655 / 1155 |
bladder | 100% | 250.71 | 21 / 21 | 50% | 2.04 | 254 / 504 |
stomach | 79% | 97.69 | 285 / 359 | 69% | 2.98 | 196 / 286 |
kidney | 100% | 99.53 | 89 / 89 | 25% | 0.53 | 226 / 901 |
pancreas | 100% | 130.95 | 327 / 328 | 21% | 0.65 | 37 / 178 |
spleen | 100% | 177.04 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 152.34 | 1196 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 139.54 | 1292 / 1335 | 0% | 0 | 0 / 0 |
heart | 91% | 88.74 | 780 / 861 | 0% | 0 | 0 / 0 |
muscle | 85% | 93.76 | 683 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 76% | 4.32 | 34 / 45 |
eye | 0% | 0 | 0 / 0 | 57% | 1.17 | 46 / 80 |
lymph node | 0% | 0 | 0 / 0 | 41% | 1.36 | 12 / 29 |
peripheral blood | 19% | 13.24 | 179 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0031519 | Cellular component | PcG protein complex |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0042393 | Molecular function | histone binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | SCML2 |
Protein name | Scm polycomb group protein like 2 (cDNA FLJ60333, highly similar to Sex comb on midleg-like protein 2) Sex comb on midleg-like protein 2 Scm polycomb group protein like 2 |
Synonyms | |
Description | FUNCTION: Putative Polycomb group (PcG) protein. PcG proteins act by forming multiprotein complexes, which are required to maintain the transcriptionally repressive state of homeotic genes throughout development (By similarity). . |
Accessions | ENST00000398048.4 [Q9UQR0-2] ENST00000251900.9 [Q9UQR0-1] H0Y6S1 ENST00000420857.6 Q9UQR0 B4DRC2 ENST00000665583.1 |